FDA Inspection
Pfizer, Inc.Pfizer, Inc. – FDA Inspection, Oct 28, 2022
Record Details
This FDA Inspection record concerns Pfizer, Inc., with an inspection on October 28, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Pfizer, Inc.
- Inspection Date
- October 28, 2022
- Product Type
- Drugs
View Company Profile
ID · 1522426b-07b3-484f-815d-78e94844b9ce
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1190580
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
Other FDA inspections of Pfizer, Inc.
25| Date | Classification | Office | Project area |
|---|---|---|---|
| October 24, 2025 | Not classified | New England District Office | |
| December 13, 2024 | VAI | New England District Office | Bioresearch Monitoring: Human Drugs |
| August 30, 2024 | Not classified | New England District Office | |
| July 19, 2024 | Not classified | New England District Office | |
| April 19, 2023 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Pfizer, Inc.
- FDA Inspection 1284680 - 2025-10-24
- FDA Inspection 1256477 - 2024-12-13
- FDA Inspection 1249289 - 2024-08-30
- FDA Inspection 1230476 - 2024-07-19
- FDA Inspection 1204434 - 2023-04-19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.